Variable | Number | Disease-free survival | Overall survival | ||
RR (95% CI) | P value | RR (95% CI) | P value | ||
Gender | |||||
Male | 77 | 1.7 (0.8 - 3.7) | 0.18 | 1.3 (1.1 - 4.8) | 0.03 |
Female | 47 | ||||
Tumor size | |||||
< | 50 | ||||
≥ | 74 | 2.2 (1.0 - 4.9) | 0.05 | 1.7 (0.8 - 3.3) | 0.15 |
Age | |||||
<65 yrs | 48 | ||||
≥65 yrs | 76 | 1.5 (0.7 - 3.2) | 0.30 | 2.0 (1.0 - 4.0) | 0.07 |
T stage | |||||
T2 | 65 | ||||
T3 | 59 | 5.0 (2.1 - 12).4) | <0.01 | 2.3 (1.2 - 4.4) | 0.02 |
N stage | |||||
Negative | 104 | ||||
Positive | 20 | 5.6 (2.7 - 11.5) | <0.01 | 3.4 (1.3 - 8.7) | 0.01 |
Lymph vessel invasion | |||||
Negative | 32 | ||||
Positive | 90 | 3.4 (1.0 - 11.2) | 0.01 | 1.5 (0.7 - 3.5) | 0.32 |
Unknown | 2 | ||||
Blood vessel invasion | |||||
Negative | 36 | ||||
Positive | 84 | 2.4 (0.9 - 6.3) | 0.07 | 1.8 (0.8 - 3.9) | 0.15 |
Unknown | 4 | ||||
Histological grade | |||||
Well differentiated | 27 | ||||
Others | 97 | 1.0 (0.4 - 2.5) | 0.93 | 0.5 (0.3 - 1.0) | 0.06 |
Intraoperative blood loss | |||||
Low | 93 | ||||
High | 31 | 3.0 (1.2 - 7.9) | 0.03 | 2.1 (0.9 - 4.7) | <0.01 |
Ezrin expression | |||||
Negative group | 87 | 4.5 (1.4 - 14.7) | 0.01 | 2.1 (0.9 - 4.7) | 0.08 |
Positive group | 37 |